@文章{信息:doi/10.2196/24982，作者="Eberle, Claudia and Loehnert, Maxine and Stichling, Stefanie"，标题="不同技术治疗妊娠期糖尿病的临床疗效:系统文献综述"，期刊="J Med Internet Res"，年="2021"，月="四月"，日="28"，卷="23"，数="4"，页数="e24982"，关键词="糖尿病技术;糖尿病管理;怀孕;数字健康;电子健康;背景:妊娠期高血糖在世界范围内都有发生，并与妇女及其后代的健康问题密切相关，如妊娠和分娩并发症，以及合并症，如代谢和心血管疾病。为了优化糖尿病妊娠的管理，迫切需要可持续的策略。需要对有助于管理妊娠和健康的不断发展的糖尿病技术进行调查。目的:我们旨在进行一项系统综述，以评估妊娠糖尿病技术的临床效果。方法:检索MEDLINE (PubMed)、Cochrane Library、Embase、CINAHL、Web of Science Core Collection等相关数据库，于2020年9月进行临床研究(2008-2020年)。 Findings were organized by type of diabetes, type of technology, and outcomes (glycemic control, pregnancy- and birth-related outcomes, and neonatal outcomes). Study quality was assessed using Effective Public Health Practice Project criteria. Results: We identified 15 randomized controlled trials, 3 randomized crossover trials, 2 cohort studies, and 2 controlled clinical trials. Overall, 9 studies focused on type 1 diabetes, 0 studies focused on gestational diabetes, and 3 studies focused on both type 1 diabetes and type 2 diabetes. We found that 9 studies were strong quality, 11 were moderate quality, and 2 were weak quality. Technologies for diabetes seemed to have particularly positive effects on glycemic control in all types of diabetes, shown by some strong and moderate quality studies. Positive trends in pregnancy-related, birth-related, and neonatal outcomes were observed. Conclusions: Technologies have the potential to effectively improve the management of diabetes during pregnancy. Further research on the clinical effectiveness of these technologies is needed, especially in pregnant women with type 2 diabetes. ", issn="1438-8871", doi="10.2196/24982", url="//www.mybigtv.com/2021/4/e24982", url="https://doi.org/10.2196/24982", url="http://www.ncbi.nlm.nih.gov/pubmed/33908894" }